229 related articles for article (PubMed ID: 12964969)
1. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease.
Pearce EN; Bogazzi F; Martino E; Brogioni S; Pardini E; Pellegrini G; Parkes AB; Lazarus JH; Pinchera A; Braverman LE
Thyroid; 2003 Jul; 13(7):643-8. PubMed ID: 12964969
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
3. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
4. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
6. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases.
Ruf J; Feldt-Rasmussen U; Hegedüs L; Ferrand M; Carayon P
J Clin Endocrinol Metab; 1994 Nov; 79(5):1404-9. PubMed ID: 7962336
[TBL] [Abstract][Full Text] [Related]
7. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced thyroid dysfunction in clinical practice.
Ursella S; Testa A; Mazzone M; Gentiloni Silveri N
Eur Rev Med Pharmacol Sci; 2006; 10(5):269-78. PubMed ID: 17121321
[TBL] [Abstract][Full Text] [Related]
9. The effects of amiodarone on the thyroid.
Martino E; Bartalena L; Bogazzi F; Braverman LE
Endocr Rev; 2001 Apr; 22(2):240-54. PubMed ID: 11294826
[TBL] [Abstract][Full Text] [Related]
10. [Amiodarone treatment and thyroid disorders].
Łacka K; Fraczek MM
Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone-induced thyrotoxicosis in a patient with autonomously functioning nodular goiter.
Liang YL; Huang SM; Peng SL; Hsiao SH; Hung HC; Ou HY; Wu TJ
Ann Pharmacother; 2009 Jan; 43(1):134-8. PubMed ID: 19109209
[TBL] [Abstract][Full Text] [Related]
12. [The effects of amiodaron on the thyroid function].
Kucharczyk P; Michałkiewicz D; Kucharczyk A
Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.
Dietlein M; Schicha H
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):145-51. PubMed ID: 15789273
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone-induced thyrotoxicosis: a review.
Tsang W; Houlden RL
Can J Cardiol; 2009 Jul; 25(7):421-4. PubMed ID: 19584973
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone-induced thyroid dysfunction.
Danzi S; Klein I
J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
[TBL] [Abstract][Full Text] [Related]
16. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.
Roti E; Minelli R; Gardini E; Bianconi L; Gavaruzzi G; Ugolotti G; Neri TM; Braverman LE
J Clin Endocrinol Metab; 1992 Nov; 75(5):1273-7. PubMed ID: 1331165
[TBL] [Abstract][Full Text] [Related]
17. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
18. Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.
Bogazzi F; Bartalena L; Dell'Unto E; Tomisti L; Rossi G; Pepe P; Tanda ML; Grasso L; Macchia E; Aghini-Lombardi F; Pinchera A; Martino E
Clin Endocrinol (Oxf); 2007 Oct; 67(4):533-7. PubMed ID: 17561980
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
[TBL] [Abstract][Full Text] [Related]
20. Thyroid ultrasonography in patients with a previous episode of amiodarone induced thyrotoxicosis.
Roti E; Bianconi L; De Chiara F; Minelli R; Tosi C; Gardini E; Salvi M; Braverman LE
J Endocrinol Invest; 1994 Apr; 17(4):259-62. PubMed ID: 7930377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
